Hirotaka Abo

Title: Hirotaka Abo: Innovator in Alkaline Phosphatase Fusion Antibodies

Introduction

Hirotaka Abo is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of alkaline phosphatase fusion antibodies. His innovative work has led to advancements in immunoassay methods, which are crucial for various diagnostic applications.

Latest Patents

Hirotaka Abo holds a patent for an "Alkaline phosphatase fusion antibody and method for producing the same, and immunoassay method." This patent discloses a method for producing an alkaline phosphatase fusion antibody. The process involves culturing a cell that contains an expression vector with genes encoding alkaline phosphatase derived from bovine small intestine or bacterium, along with a gene encoding an antibody. The method requires a medium that includes a zinc ion, allowing for the acquisition of the alkaline phosphatase fusion antibody expressed by the cell.

Career Highlights

Hirotaka Abo is currently employed at Sysmex Corporation, a company known for its innovative solutions in the field of medical diagnostics. His work at Sysmex has allowed him to apply his expertise in antibody production and immunoassay methods, contributing to the company's reputation for excellence in healthcare technology.

Collaborations

Hirotaka Abo collaborates with Nobuyuki Ide, a fellow professional in the field. Their partnership enhances the research and development efforts at Sysmex Corporation, fostering innovation and advancing the company's projects.

Conclusion

Hirotaka Abo's contributions to the field of biochemistry, particularly through his patent on alkaline phosphatase fusion antibodies, highlight his role as an influential inventor. His work continues to impact the medical diagnostics industry positively.